Torsade de pointes: Difference between revisions

	Torsades de pointes Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Torsades de pointes from other Diseases
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
EKG Examples
Echocardiography
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Torsade de pointes On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Torsade de pointes All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Torsade de pointes
CDC on Torsade de pointes
Torsade de pointes in the news
Blogs on Torsade de pointes
Directions to Hospitals Treating Torsades de pointes
Risk calculators and risk factors for Torsade de pointes

	Torsade de pointes;
DiseasesDB	29252
MeSH	D016171

VisualWikitext

Revision as of 01:48, 15 October 2012

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Clinical Correlation

Drugs: quinidine, PCA, norpace, amiodarone, phenothiazines, Tricyclic antidepressants, pentamidine.
- with quinidine majority of the cases occur within one week of initiation, and with therapeutic levels
Electrolyte imbalances: Hypokalemia, hypomagnesemia, hypocalcemia
CAD
MVP
Variant angina
Myocarditis
Subarachnoid hemorrhage
Congenital QT prolongation
Liquid protein diets
Hypothyroidism
- because of bradycardia and a prolonged QT syndrome
Organophosphate poisoning ^[1] ^[2]

Other lab studies

Electrolytes levels to rule out hypokalemia, hypomagnesemia, and hypocalcemia.
Cardiac enzymes
Echocardiography to rule out structural heart disease

Treatment

Acute Treatment

If the episode of does not terminate on its own and degenerates into ventricular fibrillation, cardioversion is required.

Lead II electrocardiogram showing Torsades being shocked by an Implantable cardioverter-defibrillator back to the patients baseline cardiac rhythm.

Once the patient is back in normal sinus rhythm, a vigorous search for and correction of conditions that predispose to torsades de pointes which include hypokalemia, hypomagnesemia, and bradycardia should be made. Magnesium sulfate (1-2 g IV over 30-60 seconds) reduces the influx of calcium thereby lowering the amplitude of early after depolarizations and should also be infused even if the magnesium is normal. ^[3]^[4] Administration of lidocaine is generally not effective, but mexiletene may be helpful in suppressing the recurrence of torsade de pointes.

Additional Information

Torsade de Pointes and Polymorphic VT

Examples

EKG's shown below are courtesy of C. Michael Gibson MS MD, and copylefted

Examples from different resources

Arrhythmias in a patient with short coupled torsade de pointes^[5]
Arrhythmias in a patient with short coupled torsades de pointes degenerating in ventricular fibrillation^[5]

Arrhythmias in a patient with short coupled torsade de pointes: frequent short coupled extrasystoles^[5]
Arrhythmias in a patient with short coupled torsade de pointes: frequent short coupled extrasystoles ^[5]

A 12 lead ECG recording example of TdP^[6]

Characteristic tracing showing the "twisting" (blue line) of Torsade de pointes

References

↑ Chou's Electrocardiography in Clinical Practice Third Edition, pp. 398-409.
↑ Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:194 ISBN 1591032016
↑ Hoshino K, Ogawa K, Hishitani T, Isobe T, Eto Y (2004). "Optimal administration dosage of magnesium sulfate for torsades de pointes in children with long QT syndrome". J Am Coll Nutr. 23 (5): 497S–500S. PMID 15466950. Unknown parameter |month= ignored (help)
↑ Hoshino K, Ogawa K, Hishitani T, Isobe T, Etoh Y (2006). "Successful uses of magnesium sulfate for torsades de pointes in children with long QT syndrome". Pediatr Int. 48 (2): 112–7. doi:10.1111/j.1442-200X.2006.02177.x. PMID 16635167. Unknown parameter |month= ignored (help)
↑ ^5.0 ^5.1 ^5.2 ^5.3 Leenhardt A, Glaser E, Burguera M, Nuernberg M, Maison-Blanche P, and Coumel P. Short-coupled variant of torsade de pointes. A new electrocardiographic entity in the spectrum of idiopathic ventricular tachyarrhythmias. Circulation 1994 Jan; 89(1) 206-15. PMID 8281648
↑ Khan IA. Twelve-lead electrocardiogram of torsade de pointes Tex Heart Inst J. 2001; 28 (1): 69. PMID 11330748

de:Torsade de pointes

Template:WikiDoc Sources

[1] Chou's Electrocardiography in Clinical Practice Third Edition, pp. 398-409.

[2] Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:194 ISBN 1591032016

[pmid15466950-3] Hoshino K, Ogawa K, Hishitani T, Isobe T, Eto Y (2004). "Optimal administration dosage of magnesium sulfate for torsades de pointes in children with long QT syndrome". J Am Coll Nutr. 23 (5): 497S–500S. PMID 15466950. Unknown parameter |month= ignored (help)

[pmid16635167-4] Hoshino K, Ogawa K, Hishitani T, Isobe T, Etoh Y (2006). "Successful uses of magnesium sulfate for torsades de pointes in children with long QT syndrome". Pediatr Int. 48 (2): 112–7. doi:10.1111/j.1442-200X.2006.02177.x. PMID 16635167. Unknown parameter |month= ignored (help)

[Leenhardt-5] 5.0 ^5.1 ^5.2 ^5.3 Leenhardt A, Glaser E, Burguera M, Nuernberg M, Maison-Blanche P, and Coumel P. Short-coupled variant of torsade de pointes. A new electrocardiographic entity in the spectrum of idiopathic ventricular tachyarrhythmias. Circulation 1994 Jan; 89(1) 206-15. PMID 8281648

[6] Khan IA. Twelve-lead electrocardiogram of torsade de pointes Tex Heart Inst J. 2001; 28 (1): 69. PMID 11330748

[1]

[2]

[3]

[4]

[5]

[6]

@@ Line 32: / Line 32: @@
 #* because of bradycardia and a prolonged QT syndrome
 # Organophosphate poisoning <ref>Chou's Electrocardiography in Clinical Practice Third Edition, pp. 398-409.</ref> <ref>Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:194 ISBN 1591032016</ref>
-==Video: Torsade de pointes==
-{{#ev:youtube|1ccTO6fNobU}}
-{{#ev:youtube|JDumoHHZocA}}
-'''Torsade de pointes is characterized by constantly changing rhythm amplitude. 'Torsade de pointes' in French means "Twisting of the Points". The changing rhythm amplitudes comes from the ventricular depolarizing waves constantly shifting its axis. It is usually caused by hypomagnesemia, hypokalemia, and malnourished alcoholics. Although Torsades de Pointes (TdP) is a rare ventricular arrhythmia, it can degenerate into ventricular fibrillation, leading to death without rapid medical intervention. TdP is associated with long QT syndrome, a condition whereby prolonged QT intervals are visible on the ECG.'''
 ==Other lab studies==


Torsade de pointes
DiseasesDB	29252
MeSH	D016171